Sandoval Elisabeth Insider Trading
Get the latest insider transactions of Sandoval Elisabeth. Sandoval Elisabeth is in Intersect ENT, Inc. ($XENT) and CCO & EVP, Corporate Strategy in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Commercial Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Commercial Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Chief Commerical Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in Menlo Therapeutics Inc. ($MNLO) and Director in Satsuma Pharmaceuticals, Inc. ($STSA). Discover the current value of Sandoval Elisabeth shares.
Address: 30930 RUSSELL RANCH ROAD 3RD FLOOR WESTLAKE VILLAGE 91362CA
Sandoval Elisabeth is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
KYTH | KYTHERA BIOPHARMACEUTICALS INC | Chief Commerical Officer, Chief Commercial Officer | 0 | 0.00 |
ALDR | ALDER BIOPHARMACEUTICALS INC | CCO & EVP, Corporate Strategy, Chief Commercial Officer | 0 | 0.00 |
MNLO | VYNE Therapeutics Inc. | Director | 0 | |
STSA | Satsuma Pharmaceuticals, Inc. | Director | 0 | |
XENT | Intersect ENT, Inc. | 0 | 0.00 |
Insider Trading Transactions of Sandoval Elisabeth
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 07 2021 | XENT | Intersect ENT, Inc. | Sandoval Elisabeth | Option Exercise | 20.98 | 15,896 | 333,498 | 15,896 | |
Aug 05 2020 | MNLO | Menlo Therapeutics Inc. | Sandoval Elisabeth | Director | Option Exercise | 1.72 | 22,500 | 38,700 | 22,500 |
Jun 16 2020 | STSA | Satsuma Pharmaceuticals, ... | Sandoval Elisabeth | Director | Option Exercise | 26.99 | 10,000 | 269,900 | 10,000 |
Mar 23 2020 | MNLO | Menlo Therapeutics Inc. | Sandoval Elisabeth | Director | Option Exercise | 2.67 | 45,000 | 120,150 | 45,000 |
Jun 27 2019 | MNLO | Menlo Therapeutics Inc. | Sandoval Elisabeth | Director | Option Exercise | 6.02 | 11,645 | 70,103 | 45,000 |
Mar 21 2019 | MNLO | Menlo Therapeutics Inc. | Sandoval Elisabeth | Director | Option Exercise | 8.24 | 33,355 | 274,845 | 33,355 |
Feb 21 2018 | ALDR | ALDER BIOPHARMACEUTICALS ... | Sandoval Elisabeth | CCO & EVP, Corporate ... | Option Exercise | 13.55 | 60,000 | 813,000 | 60,000 |
Dec 21 2017 | ALDR | ALDER BIOPHARMACEUTICALS ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 10.95 | 150,000 | 1,642,500 | 150,000 |
Jan 31 2017 | ALDR | ALDER BIOPHARMACEUTICALS ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 20.40 | 75,000 | 1,530,000 | 75,000 |
Oct 07 2016 | ALDR | ALDER BIOPHARMACEUTICALS ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 31.47 | 225,000 | 7,080,750 | 225,000 |
Oct 02 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commerical Offi ... | Sell | 0.00 | 575 | 0 | 0 |
Oct 02 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commerical Offi ... | Option Exercise | 8.22 | 45,588 | 374,907 | 0 |
Oct 02 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commerical Offi ... | Option Exercise | 27.50 | 6,700 | 184,250 | 0 |
Oct 02 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commerical Offi ... | Option Exercise | 44.02 | 15,608 | 687,064 | 0 |
Oct 02 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commerical Offi ... | Option Exercise | 38.53 | 45,344 | 1,747,104 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Buy | 8.22 | 10,590 | 87,050 | 10,590 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Sell | 74.90 | 10,590 | 793,191 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Buy | 8.22 | 11,892 | 97,752 | 11,892 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Sell | 74.90 | 11,892 | 890,711 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Buy | 8.22 | 22,690 | 186,512 | 22,690 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Sell | 74.90 | 22,690 | 1,699,481 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Buy | 27.50 | 26,800 | 737,000 | 26,800 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Sell | 74.90 | 26,800 | 2,007,320 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Buy | 44.02 | 11,150 | 490,823 | 11,150 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Sell | 74.90 | 11,150 | 835,135 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 8.22 | 10,590 | 87,050 | 16,749 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 8.22 | 11,892 | 97,752 | 4,857 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 8.22 | 22,690 | 186,512 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 27.50 | 13,400 | 368,500 | 0 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 27.50 | 13,400 | 368,500 | 6,700 |
Sep 24 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Option Exercise | 44.02 | 11,150 | 490,823 | 15,608 |
Aug 06 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Sell | 74.75 | 2,728 | 203,918 | 0 |
Apr 30 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Buy | 0.00 | 4,382 | 0 | 4,382 |
Apr 30 2015 | KYTH | KYTHERA BIOPHARMACEUTICAL ... | Sandoval Elisabeth | Chief Commercial Offi ... | Sell | 45.55 | 1,654 | 75,340 | 2,728 |